Literature DB >> 8134353

Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo.

J E McCormack1, J Kappler, P Marrack.   

Abstract

The T-cell response to pigeon cytochrome c peptide, residues 88-104 (pcytC), in B10.BR mice is mediated largely by cells bearing both V beta 3 and V alpha 11 variable regions of the T-cell antigen receptor. These cells are, therefore, reactive with the superantigen staphylococcal enterotoxin A (SEA). Recent reports have shown that in vivo exposure to superantigen can lead to deletion of superantigen-reactive T cells from the pool of mature T cells in the periphery. Here we show that upon cotreatment of animals with both SEA and pcytC, bulk deletion of the population of SEA-reactive cells is maintained, while the subpopulation of SEA-reactive T cells that also responds to pcytC is not deleted but instead proliferates in response to pcytC. These results are discussed with regard to mechanisms regulating the balance between T-cell tolerance and T-cell activation in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134353      PMCID: PMC43314          DOI: 10.1073/pnas.91.6.2086

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  B cells turn off virgin but not memory T cells.

Authors:  E J Fuchs; P Matzinger
Journal:  Science       Date:  1992-11-13       Impact factor: 47.728

2.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

3.  SEB induced anergy: modulation of immune response to T cell determinants of myoglobin and myelin basic protein.

Authors:  A Gaur; C G Fathman; L Steinman; S Brocke
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Limited usage of T cell receptor V beta genes by allopeptide-specific T cells.

Authors:  Z Liu; Y K Sun; Y P Xi; B Hong; P E Harris; E F Reed; N Suciu-Foca
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

6.  Infection breaks T-cell tolerance.

Authors:  M Röcken; J F Urban; E M Shevach
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

7.  Limited T cell receptor beta-chain usage in the sperm whale myoglobin 110-121/E alpha dA beta d response by H-2d congenic mouse strains.

Authors:  K S Sellins; J S Danska; V Paragas; C G Fathman
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

8.  Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen.

Authors:  J E McCormack; J E Callahan; J Kappler; P C Marrack
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

9.  Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor.

Authors:  J White; A Pullen; K Choi; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

10.  Memory T cells are anergic to the superantigen staphylococcal enterotoxin B.

Authors:  W T Lee; E S Vitetta
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Immunosuppression through blockade of CD28:B7-mediated costimulatory signals.

Authors:  T A Judge; A Tang; L A Turka
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  The superantigen Staphylococcus enterotoxin B induces a strong and accelerated secondary T-cell response rather than anergy.

Authors:  H Schultz; A Geiselhart; G Sappler; D Niethammer; M K Hoffmann; G E Dannecker
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

3.  The in vivo mechanism of action of CTLA4Ig.

Authors:  T A Judge; A Tang; L M Spain; J Deans-Gratiot; M H Sayegh; L A Turka
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

4.  Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation.

Authors:  Paula M Oliver; Xiao Cao; George Scott Worthen; Peijun Shi; Natalie Briones; Megan MacLeod; Janice White; Patricia Kirby; John Kappler; Philippa Marrack; Baoli Yang
Journal:  Immunity       Date:  2006-11-30       Impact factor: 31.745

5.  Impaired thymic selection and abnormal antigen-specific T cell responses in Foxn1(Δ/Δ) mutant mice.

Authors:  Shiyun Xiao; Nancy R Manley
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

6.  In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.

Authors:  S W Dow; R E Elmslie; A P Willson; L Roche; C Gorman; T A Potter
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells.

Authors:  Baoli Yang; Denise L Gay; Megan K L MacLeod; Xiao Cao; Tamara Hala; Eileen M Sweezer; John Kappler; Philippa Marrack; Paula M Oliver
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

Review 8.  Superantigens in human disease.

Authors:  A Bernal; T Proft; J D Fraser; D N Posnett
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.542

9.  Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide.

Authors:  S Marusić; S Tonegawa
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

10.  Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.

Authors:  A E Lukacher; Y Ma; J P Carroll; S R Abromson-Leeman; J C Laning; M E Dorf; T L Benjamin
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.